Draganfly Earns New Record Fourth Quarter Sales and New Record Annual Sales
April 04, 2022 08:40 ET
|
Draganfly Inc
Los Angeles, CA., April 04, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solution developer...
Incysus Therapeutics to Present at LifeSci Partners Summer Symposium
August 03, 2020 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell...
Incysus Therapeutics Initiates Enrollment in Phase 1 Study of a Genetically Modified Gamma-Delta (γδ) T Cell Immunotherapy in Patients with Newly Diagnosed Glioblastoma
February 27, 2020 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
National Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement Award
May 18, 2019 17:45 ET
|
National Lipid Association
MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown...
Incysus Therapeutics Announces FDA Approval of IND Application for a Novel Gamma-Delta (γδ) T Cell Therapy for Treatment of Patients With Newly-Diagnosed Glioblastoma
April 01, 2019 08:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Gamma-Delta T Cell Immunotherapy Pioneer, Lawrence Lamb, PhD, to Join Incysus Therapeutics as Chief Scientific Officer
January 03, 2019 14:30 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
University of Alabama Professor Elected to the American College of Prosthodontists Board of Directors
December 28, 2017 11:23 ET
|
American College of Prosthodontists
Chicago, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daniel A. Givan, DMD, PhD, FACP, was elected as Secretary for the Board of Directors of the American College of Prosthodontists (ACP), the national...
Blazing a new trail: Former UAB running back helps lead football resurgence
May 22, 2017 13:32 ET
|
Juke Slot
Birmingham, Alabama, May 22, 2017 (GLOBE NEWSWIRE) -- When the University of Alabama at Birmingham sidelined its football program after the 2014 season because of a lack of funding, Jegil Dugger...
The University of Alabama at Birmingham Selects Apogee to Boost Network Speeds and Wi-Fi for Five Residential Halls
August 12, 2014 10:10 ET
|
Apogee
AUSTIN, TX--(Marketwired - Aug 12, 2014) - Apogee, higher education's largest residential network (ResNet) provider, announced today that the company has been selected by the University of Alabama...